Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Therapure Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10923
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Therapure Biopharma Inc (Therapure) is a biotherapeutics company that enhances patient care through its three divisions: therapure biomanufacturing, therapure innovations and evolve biologics. The company’s therapure biomanufacturing division offers pipeline products such as TBI 301, TBI 302 and TBI 304H. Its company’s therapure innovations operate as a proprietary drug development division and uses proprietary protein technologies for the treatment of diseases such as anemia, liver cancer, and hepatitis C. Therapure’s services include purification, development, manufacture, and packaging of therapeutic proteins and follow-on biologics. The company operates through bio-pharmaceutical companies in across the world. Therapure is headquartered in Mississauga, Ontario, Canada.

Therapure Biopharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Therapure Biopharma To Acquire Plasma Protein Purification Technology From Upfront Chromatography 10
Private Equity 12
Catalyst Capital Group May Sell Therapure Biopharma for USD300 Million 12
Equity Offering 13
Therapure Biopharma Postpones IPO 13
Asset Transactions 14
10363782 Canada to Acquire CDMO Business from Therapure Biopharma for USD290 Million 14
Therapure Biopharma Inc – Key Competitors 15
Therapure Biopharma Inc – Key Employees 16
Therapure Biopharma Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 23, 2018: Therapure Biopharma Launches Biologics Division as Evolve Biologics, an Innovative Plasma-Derived Therapeutics Company 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Therapure Biopharma To Acquire Plasma Protein Purification Technology From Upfront Chromatography 10
Catalyst Capital Group May Sell Therapure Biopharma for USD300 Million 12
Therapure Biopharma Postpones IPO 13
10363782 Canada to Acquire CDMO Business from Therapure Biopharma for USD290 Million 14
Therapure Biopharma Inc, Key Competitors 15
Therapure Biopharma Inc, Key Employees 16
Therapure Biopharma Inc, Other Locations 17

List of Figures
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung C&T Corp:企業のM&A・事業提携・投資動向
    Samsung C&T Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Samsung C&T Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • AdvantEdge Healthcare Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Acciona Energia SA:企業の戦略的SWOT分析
    Acciona Energia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Smiths Group Plc (SMIN):医療機器:M&Aディール及び事業提携情報
    Summary Smiths Group Plc (Smiths Group) is a diversified technology company. It offers critical solutions for energy and process industries, medical devices and consumables, devices for detection and identification of security threats and contraband, solutions for high speed connectivity and compone …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • KPIT Technologies Ltd (BSOFT):企業の財務・戦略的SWOT分析
    KPIT Technologies Ltd (BSOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that develops products for ophthalmic, fibrotic diseases and cancers. The company offers antisense technology based drugs that treats aggressive tumor diseases. Its product include TGF-ß, a in …
  • SThree Plc (STHR):企業の財務・戦略的SWOT分析
    Summary SThree Plc (Sthree) is a staffing company that offers permanent and contract staffing business. The company operates through its sectors such as information and communications technology (ICT), energy, engineering, life sciences, banking and finance. Its business brands such as Computer Futu …
  • Neste Corporation (NESTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Neste Corp (Neste) is an oil refining and marketing company that offers advanced, clean traffic fuels besides shipping and engineering services. The company produces and sells gasoline; diesel fuel; aviation fuel; bunker fuel; heating oil; light and heavy fuel oil; base oils; gasoline compon …
  • AMEWAS, Inc.:企業の戦略・SWOT・財務分析
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Crohn’s & Colitis Foundation Inc-製薬・医療分野:企業M&A・提携分析
    Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization which focuses on providing treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. CCF’s partners in …
  • Bouygues Group:戦略・SWOT・企業財務分析
    Bouygues Group - Strategy, SWOT and Corporate Finance Report Summary Bouygues Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Gold Road Resources Ltd (GOR):企業の財務・戦略的SWOT分析
    Summary Gold Road Resources Ltd (GRRL), formerly Eleckra Mines Ltd, is a mining and mineral exploration and development company that offers mining services. The company acquires, explores and develops iron, gold, nickel and mineral deposits properties. Its projects comprise Gruyere project, Yamarna …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Vanderbilt University:製薬・医療:M&Aディール及び事業提携情報
    Summary Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as c …
  • NTT Communications Corporation:企業のM&A・事業提携・投資動向
    NTT Communications Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT Communications Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Nufarm Limited:企業の戦略・SWOT・財務情報
    Nufarm Limited - Strategy, SWOT and Corporate Finance Report Summary Nufarm Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Luitpold Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Luitpold Pharmaceuticals Inc (Luitpold), a subsidiary of Daiichi Sankyo Company Ltd is a manufacturer and marketer of drugs and medical devices. The company provides injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, antidotes, critical care drugs, …
  • National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報
    Summary National Health Research Institutes (NHRI) is a non-profit foundation that performs medical research programs. The foundation investigates various aspects of basic biomedical sciences and diseases including aging, cancer, infectious diseases, mental disorders and occupational diseases. It co …
  • SAG. Solar GmbH & Co KG-エネルギー分野:企業M&A・提携分析
    Summary S.A.G. Solar GmbH & Co. KG. (S.A.G. Solar), a subsidiary of Shunfeng International Clean Energy Limited, is a manufacturer of photovoltaic systems. The company constructs, installs, operates and integrates solar power plants. It constructs rooftop systems, roof and facade-integrated systems, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆